Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2023 Apr 6;18(4):e0283958. doi: 10.1371/journal.pone.0283958

Is information provided within chronic subdural haematoma education resources adequate? A scoping review

Conor S Gillespie 1,2, Samuel Khanna 3, Mark E Vivian 3, Samuel McKoy 2, Alvaro Yanez Touzet 4, Ellie Edlmann 1, Daniel J Stubbs 3, Benjamin M Davies 1,*
Editor: Sara Rubinelli5
PMCID: PMC10079037  PMID: 37023014

Abstract

Background

Chronic subdural haematoma (CSDH) is becoming increasingly prevalent, due to an aging population with increasing risk factors. Due to its variable disease course and high morbidity, patient centred care and shared decision making are essential. However, its occurrence in frail populations, remote from specialist neurosurgeons who currently triage treatment decisions, challenges this. Education is an important component of enabling shared decisions. This should be targeted to avoid information overload. However, it is unknown what this should be.

Objectives

Our objectives were to conduct analysis of the content of existing CSDH educational materials, to inform the development of patient and relative educational resources to facilitate shared decision making.

Methods

A literature search was conducted (July 2021) of MEDLINE, Embase and grey literature, for all self-specified resources on CSDH education, and narrative reviews. Resources were classified into a hierarchical framework using inductive thematic analysis into 8 core domains: Aetiology, epidemiology and pathophysiology; natural history and risk factors; symptoms; diagnosis; surgical management; nonsurgical management; complications and recurrence; and outcomes. Domain provision was summarised using descriptive statistics and Chi-squared tests.

Results

56 information resources were identified. 30 (54%) were resources designed for healthcare professionals (HCPs), and 26 (46%) were patient-orientated resources. 45 (80%) were specific to CSDH, 11 (20%) covered head injury, and 10 (18%) referenced both acute and chronic SDH. Of 8 core domains, the most reported were aetiology, epidemiology and pathophysiology (80%, n = 45) and surgical management (77%, n = 43). Patient orientated resources were more likely to provide information on symptoms (73% vs 13%, p<0.001); and diagnosis (62% vs 10%, p<0.001) when compared to HCP resources. Healthcare professional orientated resources were more likely to provide information on nonsurgical management (63% vs 35%, p = 0.032), and complications/recurrence (83% vs 42%, p = 0.001).

Conclusion

The content of educational resources is varied, even amongst those intended for the same audience. These discrepancies indicate an uncertain educational need, that will need to be resolved in order to better support effective shared decision making. The taxonomy created can inform future qualitative studies.

Introduction

Chronic subdural haematoma (CSDH) is commonly encountered in neurosurgery [1]. With an incidence of 1.7–20.6 per 100,000 per year [2], cases are predicted to rise in line with an ageing population, increasing frequency of head injuries, and use of antiplatelet and/or anticoagulant medication [3]. This is forecast to increase operative workload by 50% in the next 20 years [4, 5].

The CSDH disease course can vary considerably, and several care decisions may be encountered. The principal decision is often whether surgical drainage is required, and how urgently. Surgery is offered to patients with symptoms resulting from mass effect such as neurological deficits and/or reduced consciousness level [1]. Further decisions may then include the type of surgery and anaesthesia, or increasingly the role of interventional radiology, although this is still at the experimental stage [6]. They may include the timing of surveillance imaging, or pre-operative optimisation for patients on anti-thrombotics or with acute medical problems [7]. These decisions are often not clear cut, particularly given the co-existent morbidity and frailty amongst people with CSDH and must be individualised. To do this, decisions must involve the patients and their families/carers; the critical stakeholders [8].

For CSDH this process is often more challenging as neurosurgery is a tertiary speciality, and many hospitals will not have on-site access to neurosurgical services or specialists: In some centres, over 90% of cases may be referred from other non-specialist hospitals [911]. High-quality evidence in the care of CSDH is centred on operative and tertiary centre care–with randomised trials only providing clear evidence on some aspects of operative technique [12] and adjunctive steroid use [13]. This compounds the difficulties as care decisions pertinent to local hospitals are more likely to contain significant uncertainties, and instead rely on contextual information and judgement.

However before a shared decision making process can commence, patients and their families must acquire sufficient knowledge of the condition [14]. Healthcare professionals often employ aids to help bridge this knowledge gap. These could include websites, educational videos, and/or condition leaflets. Whilst potentially effective, designed by professionals these are at risk of imposing a bias on what information is portrayed, and/or can be generic in nature–poorly tailored to the decision/context in question. This can risk information overload, and potentially confuse and/or hinder an effective shared decision-making process [9]. In CSDH, the content, appropriateness and availability of resources available to patients is poorly researched, with little information available [1517].

Our objectives are aligned with this. Firstly, we sought to identify and explore the information themes that are found in educational resources for CSDH (available to professionals, patients, families, and caregivers). Our secondary objectives were to identify current knowledge gaps in the content of resources aimed at patients to healthcare professionals, to help in the development of future materials to facilitate shared decision making [18]. The overall objective of the study was to identify the information provided in CSDH educational resources.

Materials and methods

Resource type and categorisation

In line with health seeking behaviour of both the general public and healthcare professionals [19] potential educational information resources were defined as published articles (narrative reviews published in a peer-reviewed journal), other healthcare professional orientated resources, general health education websites and patient information leaflets. All resources available covering CSDH that could be considered educational resources, were included. Narrative reviews were selected because narrative reviews typically aim to provide educational content, and systematic reviews focus on specific clinical questions [20, 21]. This methodology was formulated from a previously published scoping review on educational resources in degenerative cervical myelopathy- this confirmed most systematic reviews examined a clinical research question rather than provide educational content [22]. To consider an information bias (i.e. whereby CSDH relevant information was missing from lay content), we included resources intended for healthcare professionals as well as patients and/or relatives.

Dedicated searches were performed for each media type, for content exclusively addressing CSDH. Content covering both acute (ASDH) and chronic SDH that did not differentiate between the two diagnoses, was excluded (Table 1). The search strategy is summarised below.

Table 1. Overall inclusion and exclusion criteria for screening resources to identify those with educational CSDH content.

Inclusion Criteria Exclusion Criteria
English language Do not specify CSDH in resource OR only specified ASDH
Data source identifies as an educational resource/tool OR is a narrative review
Chronic Subdural Haematoma OR Acute Subdural Haematoma Plus Chronic Subdural Haematoma OR Head Injury Plus Chronic Subdural Haematoma

These criteria were applied to screen resources from the 4 key resource types: scientific research articles, other healthcare professional orientated content, health education websites and patient information leaflets. The aim was to identify public-facing resources that contained educational content on CSDH. Specific inclusion and exclusion criteria were then adapted for each resource type.

Search strategy

A search was developed and refined for each of the four information types (Fig 1). For website-based resources, a hierarchical search strategy was employed to identify CSDH educational content with sequential searching of identified websites using page navigation, site search facilities, and finally in-page searching for the term ‘Chronic Subdural Haematoma’. Websites were chosen based on their popularity as a health information resource, as defined in a previous review [22].

Fig 1. Sources and searches used to identify resource.

Fig 1

Resource type acquisition and searching

For scientific literature, we used the term ‘Chronic Subdural Haematoma’ to search the EMBASE, Medline, and PROSPERO databases from 1st January 2016 until 21st July 2021 for narrative reviews. This time frame was selected to identify the most recent reviews published on CSDH, and to provide a representation of contemporary CSDH educational content. Videos and health education websites were identified by carrying out a search using Google (CA, USA) on 9th July 2021, including the top 10 results pages. For hospital patient information leaflets, we manually searched all United Kingdom (UK) and Republic of Ireland (ROI) Neurosurgical units listed on the Society of British Neurological Surgeons (SBNS) website [23], looking for CSDH educational resources. Searches were conducted by two authors (MEV and SK) with arbitration of inclusion and exclusion criteria by a third (DJS).

Data extraction and coding

Educational information was extracted in duplicate by two independent authors (CSG and SM), and if disagreements could not be resolved by consensus, senior authors (DJS or BMD) were consulted for clarification. Extracted information was coded by inductive thematic analysis [24] by two authors (CSG and BMD) into a hierarchical framework of ‘domains’ and ‘subdomains’. This included eight domains (Fig 2): Aetiology, epidemiology and pathophysiology; natural history and risk factors; symptoms; diagnosis; surgical management; nonsurgical management; complications and recurrence; and outcomes, alongside a number of subdomains (Fig 2).

Fig 2. Key education domains for CSDH, devised by inductive thematic analysis.

Fig 2

These were developed independently by assessing all information resources, and were refined through an iterative process until they were deemed applicable across all content, and consensus between authors was reached. For the domain ‘symptoms’, seven frequently encountered symptoms were selected by consensus to represent the subdomains [25]. Additional criteria were used to determine if a resource was targeted at a patient, carer or relative; healthcare professional (HCP) or both. A resource was defined as targeted at HCPs If it was published in a peer reviewed journal, or self-identified as ‘being for use by healthcare professionals’ specifically. All other resources were classified as targeted at patients. If a resource explicitly stated in its title or heading that it was for use by patients and HCPs, it was categorised as both.

Statistical analysis

Data analysis was conducted using R V4.0.2, and figures created using RStudio (ggplot2, fsmb, and ggthemes packages). Data was summarised using descriptive statistics. The Chi square test was used to compare differences between HCP resources and patient education resources except in the case of individual cell counts of five or less where Fisher’s exact test was used. We considered a p value <0.05 to be significant.

Results

Of the 100 potential resources identified from 10 results pages, 56 information resources were identified as eligible for inclusion. These included 26 patient-targeted resources, and 30 scientific articles targeted at HCPs. The 26 patient resources included 20 websites, 4 leaflets, 1 review article and 1 video. 45 (80%) were specific to CSDH, 11 (20%) represented head injury but included CSDH information, and 10 (18%) referenced both acute and chronic SDH.

Core domains

The core domains for all resources are shown in Fig 3 and Table 2. The most common domains addressed were Aetiology, Epidemiology and Pathophysiology (80%, n = 45), Surgical management (77%, n = 43), and Natural history and risk factors (73%, n = 41). The least common included domains were Diagnosis (34%, n = 19), Symptoms (41%, n = 23) and Nonsurgical management (50%, n = 28). Most resources were designed for HCPs (54%, n = 30). Some were designed for patients, carers and the public (46%, n = 26), with 1 designed for both patients and HCPs (2%).

Fig 3. Population pyramid of differences between domains, stratified by resource- target audience (Healthcare professional (HCP) or patient/relative-focused).

Fig 3

Table 2. Differences in domain components between patient orientated and healthcare professional orientated resources.

Title Code Overall (%, n) Patient Resources %, (n) Healthcare professional (HCP) resources % (n) P value
Aetiology, Epidemiology, Pathophysiology 1 80 (45) 77 (20) 83 (25) 0.547
Anatomy 1a 50 (28) 69 (18) 33 (10) 0.007*
Definitions 1b 48 (27) 65 (17) 33 (10) 0.017*
Aetiology 1c 55 (31) 58 (15) 53 (16) 0.743
Epidemiology 1d 38 (21) 12 (3) 60 (18) <0.001*
Pathophysiology 1e 46 (26) 42 (11) 50 (15) 0.565
Natural history and risk factors 2 73 (41) 77 (20) 70 (21) 0.560
Natural history 2a 48 (27) 58 (15) 40 (12) 0.186
Risk factors 2b 67 (39) 73 (19) 67 (20) 0.603
Head Injury 2bi 50 (28) 58 (15) 43 (13) 0.284
Trivial head trauma 2bii 36 (20) 39 (10) 33 (10) 0.690
Elderly 2biii 57 (32) 58 (15) 68 (17) 0.938
Cerebral atrophy 2biv 41 (23) 54 (14) 30 (9) 0.070
Alcohol 2bv 32 (18) 62 (16) 7 (2) <0.001*
Infant 2bvi 5 (3) 12 (3) 0 (0) 0.056
Antiplatelets 2bvii 33 (18) 52 (13) 17 (5) 0.005
Anticoagulants 2bviii 45 (25) 58 (15) 33 (10) 0.067
Hypotension 2bix 5 (3) 4 (1) 7 (2) 0.640
Symptoms 3 41 (23) 73 (19) 13 (4) <0.001*
Headache 3a 39 (22) 69 (18) 13 (4) <0.001*
Appetite loss 3b 5 (3) 8 (2) 3 (1) 0.470
Nausea 3c 30 (17) 62 (16) 3 (1) <0.001*
Vomiting 3d 30 (17) 62 (16) 3 (1) <0.001
Weakness/Focal Neurological deficit 3e 36 (20) 65 (17) 10 (3) <0.001*
Reduced consciousness/GCS 3f 41 (23) 73 (19) 13 (4) <0.001*
Ataxia 3g 25 (14) 46 (12) 7 (2) <0.001*
Diagnosis 4 34 (19) 62 (16) 10 (3) <0.001*
Clinical assessment 4a 27 (15) 50 (13) 7 (2) <0.001*
Radiological assessment 4b 36 (20) 58 (15) 17 (5) 0.002*
Blood test assessment 4c 14 (8) 23 (6) 7 (2) 0.085
Differential diagnosis 4d 13 (7) 27 (7) 0 (0) 0.003*
Surgical management 5 77 (43) 69 (18) 83 (25) 0.213
Any Surgical approach 5a 70 (39) 62 (16) 77 (23) 0.219
Decision/rationale for surgical approach 5b 34 (19) 39 (10) 30 (9) 0.505
Burr Holes 5c 73 (41) 62 (16) 83 (25) 0.066
Twist Drill 5d 34 (19) 8 (2) 57 (17) <0.001*
Craniotomy 5e 59 (33) 54 (14) 63 (19) 0.472
Craniectomy 5f 7 (4) 8 (2) 7 (2) 0.882
Surgical drain 5g 25 (14) 15 (4) 33 (10) 0.122
Nonsurgical management 6 50 (28) 35 (9) 63 (19) 0.032*
No interventions 6a 32 (18) 31 (8) 33 (10) 0.838
Steroids 6b 27 (15) 12 (3) 40 (12) 0.016*
MMA embolization 6c 20 (11) 0 (0) 37 (11) <0.001*
Mannitol 6d 4 (2) 4 (1) 3 (1) 0.918
Hypertonic saline 6e 2 (1) 4 (1) 0 (0) 0.464
Other medications 6f 29 (16) 8 (2) 47 (14) 0.001*
Complications and recurrence 7 64 (36) 42 (11) 83 (25) 0.001*
Frequency of Recurrence 7a 46 (26) 8 (2) 80 (24) <0.001*
Factors associated with recurrence 7b 46 (26) 12 (3) 77 (23) <0.001*
Recurrence treatment- surgical 7c 25 (14) 4 (1) 43 (13) <0.001*
Recurrence treatment- non surgical 7d 27 (15) 12 (3) 40 (12) 0.016*
Complications- frequency 7e 48 (27) 31 (8) 63 (19) 0.015*
Complications- list 7f 48 (27) 31 (8) 63 (19) 0.015*
Outcomes 8 66 (37) 58 (15) 73 (22) 0.218
Survival 8a 36 (20) 15 (4) 53 (16) 0.003*
Morbidity/Quality of Life 8b 46 (26) 54 (14) 40 (12) 0.300
Long term effects 8c 50 (28) 54 (14) 47 (14) 0.592
Support organisations 8d 21 (12) 46 (12) 0 (0) <0.001*

Differences between HCP resources and patient resources

The differences in information provided between the two groups are shown in Table 2 and Fig 3. There was a significant difference in reporting of four domains- patient resources were more likely to provide information on Symptoms (73% vs 13%, p<0.001) and Diagnosis (62% vs 10%, p<0.001). HCP resources were more likely to provide information on Nonsurgical management (63% vs 35%, p = 0.032), and complications and recurrence (83% vs 42%, p = 0.001).

Domain summaries

Domain 1: Aetiology, epidemiology, and pathophysiology

Commonly reported sub-domains included Aetiology (55%, n = 31) and Anatomy (50%, n = 28). Patient resources more frequently defined CSDH, separating it from an ASDH (65% vs 33%, p = 0.017) and described anatomy (69% vs 33%, p = 0.007), whilst HCP resources were more likely to describe epidemiology (60% vs 12%, p<0.001).

Domain 2: Natural history and risk factors

The most commonly reported sub-domain was the reporting of any risk factors such as head injury, alcohol misuse, and medications (70%, n = 39). For specific risk factors reported, patient resources described more alcohol misuse (62% vs 7%, p<0.001), and antiplatelet medication use (52% vs 17%, p = 0.005) than HCP resources.

Domain 3: Symptoms

The most commonly reported symptoms overall were confusion/loss of consciousness (41%, n = 23), headache (39%, n = 22), and weakness/focal neurological deficit (36%, n = 20). Patient resources covered 6/7 symptoms more frequently than HCP resources (headache, appetite loss, nausea, vomiting, weakness/FND, and reduced consciousness level/GCS).

Domain 4: Diagnosis

The most commonly reported component of diagnosis was radiological assessment (36%. N = 20). HCP resources reported all sub-domains more frequently than patient resources.

Domain 5: Surgical management

Surgical management was highly reported in all resources (77%, n = 43). The most frequently reported surgical treatment was burr holes (73%, n = 41). HCP resources were more likely to report the use of Twist Drill craniotomy compared to patient resources (66% vs 8%, p<0.001). There was no significant difference in reporting of rationale for surgical approach (39% vs 30%, p = 0.505), burr holes (62% vs 83%, p = 0.066), Craniotomy (54% vs 63%, p = 0.472), craniectomy (8%, vs 7%, p = 0.882), and surgical drain use (15% vs 33%, p = 0.122). There was no reporting on anaesthetic use in either resource type.

Domain 6: Nonsurgical management

The most commonly reported sub-domains in nonsurgical management was conservative management, with no intervention (32%, n = 18). HCP resources had higher reporting of steroids and dexamethasone use (40% vs 12%, p = 0.016), Middle meningeal artery (MMA) embolization (37% vs 0%, p<0.001), and other medications (47% vs 8%, p = 0.001).

Domain 7: Complications and recurrence

The most frequently reported sub domains were complications- frequency and listing of complications (both 48%, n = 27). HCP resources were more likely to report all sub-domains, including frequency of recurrence (83% vs 42%, p<0.001), factors associated with recurrence (77% vs 12%, p<0.001), surgical treatment of recurrence (43% vs 4%, p<0.001), nonsurgical treatment of recurrence (40% vs 12%, p = 0.016), frequency of complications (63% vs 31%, p = 0.015), and list of complications (63% vs 31%, p = 0.015).

Domain 8: Outcomes

The most frequently reported outcomes were long term functional effects of a CSDH (50%, n = 28), and morbidity/quality of life (46%, n = 26). HCP resources reported information relating to survival more commonly than patient resources (53% vs 15%, p = 0.003). Patient resources provided information on support organisations more than HCP resources (46% vs 0%, p<0.001). There was no reporting on long-term anticoagulation management for either resource type.

Discussion

In this scoping review we identified and analysed 56 educational resources, targeted at professionals, patients, carers and/or the public. These resources predominantly aim to focus on management strategies, and aetiology and epidemiology, with wide differences in coverage between HCP aimed resources, and patient resources. Information provision differed by and within audience type. HCP resources focused on surgical management and complications, whilst patient resources covered natural history, symptoms and diagnosis. Over eight in ten of resources provided information on the aetiology, epidemiology, and pathophysiology of CSDH; however less than half provided information on symptoms and diagnosis.

HCP resources focussed on management, surgical and/or non-surgical. This is in-line with the current focus of CSDH research; interventions or surgical techniques [26, 27] and adjuvant therapies such as steroids [28], antiepileptic medications [29] and statins [30]. Less than one-sixth of HCP resources included information on symptoms or diagnosis. Scientific articles are likely to be read by HCPs, particularly those with a specialist interest. Therefore, it is feasible that symptoms and diagnosis would be less commonly covered, due to inferred existing knowledge. However, this will not represent all HCPs that manage CSDH. Our findings elsewhere indicate the majority of patient HCP interactions in CSDH, are by HCP without a specialist interest in CSDH [31]. For example, most patients present with CSDH at non-specialist hospitals without access to a neurosurgical unit and are referred to a tertiary external neurosurgery unit (NSU) for advice, guidance, and potential transfer [10]. Not only do they often provide the direct and long-term care, but they will also facilitate shared decision making. In particular, literature is lacking on symptoms and diagnosis of CSDH- this may have an adverse impact on early recognition and diagnosis. Late diagnosis of CSDH has been associated with worse outcomes [32], and therefore recognising CSDH early, particularly in older patients with ambiguous presentations, is vital [33].

Assumptions on the needs of the audience were potentially present in the patient resources. Here information overwhelmingly focused on symptoms and diagnosis with little provided on long term outcomes. This could be due to the intent of resources to inform patients and carers of the fundamental principles of CSDH, and not its long-term prognosis. However, this may not cover all information needs, for example when considering the decision of surgical management. Surgery has a reported recurrence rate of between 8 and 30% [13], with a risk of adverse effects and long term implications for cognition and quality of life [34, 35]. Such information would theoretically be important for effective shared decision making.

Within patient resources, further content potentially pertinent to shared decisions were missing. Examples included mode of anaesthesia, management of anticoagulation or antiplatelet use, but also non-surgical management strategies. This again could be due to the resource focus, but may also reflects the quality of evidence for these topics. However the availability of evidence is not necessarily a surrogate of need. UK national audit data suggests that although a majority of non-operative cases did not have surgery due to the small size of their CSDH, a significant portion did not have surgery due to either futility or best-interests decisions [11]. Arguably these groups have distinct information needs, and further work should explore what information individuals belonging to this non-operative cohort require. Frailty and baseline function highly influence this, and as they form part of this decision-making process, should also be considered in CSDH educational materials to facilitate intervention discussions among patients and families [36].

Middle Meningeal Artery (MMA) embolization and other experimental nonsurgical treatments are emerging management strategies for CSDH [37] and were not explored by patient resources, despite their increasing usage by some centres [37]. This would align with a preference for evidence or knowledge to inform educational content, rather than the clinical need [38].

In regard to reporting of symptoms, increasing age was the most reported risk factor in HCP resources. This has been demonstrated to be one of the most significant factors associated with CSDH development [39]. In contrast amongst patient resources, alcohol misuse was the most commonly reported risk factor. Whilst age may have been omitted as unmodifiable, the better-known associations of antiplatelets and anticoagulants was also rarely mentioned [4042]. It is not known if patients are informed about these risks, which is crucial to promote shared decision making and patient autonomy.

Overall, the varied education provision in resources ultimately indicate an uncertainty over the exact educational need for CSDH amongst both patients and HCPs, with current provision emphasising CSDH as a whole disease process, as opposed to individual decisions required at points in the patient journey.

Comparisons to previously published studies

These findings are in keeping with the broader, albeit limited neurosurgical literature. A previous systematic review examining surgeon-patient communication in neurosurgery identified that patient comprehension was low, and informational needs were often unmet, causing patient dissatisfaction [17]. This suggests that a mismatch of information can exist between clinicians and patients, despite information being available further raising questions around the preferred method of delivery. Limited studies of patient education resources have reported high satisfaction; but this still remains limited to self-produced resources [43]. Despite videos being rated by patients as the most effective medium for enforcing communication [44], there was only one resource available that utilised this approach. Patient based resources in CSDH have been scarcely researched, but studies examining Traumatic Brain Injury (TBI) based resources have demonstrated poor global quality, in keeping with the findings of our study [45].

Limitations

Our study has several limitations; firstly, core domain selection was obtained by thematic analysis with the writing group, which did not include patients. This may result in skewed selection. However we tried to be as broad as possible in our definitions, and many of the domains identified and addressed within resources are highlighted as important in the James Lind Alliance priority setting partnership [46], indicating coverage of key patient priorities. Second, the search strategy was not all-encompassing, and does not include every published systematic review on CSDH, nor consider every digital health education resource. Physical resources such as patient self-help groups, and local patient care centres, or alternative health platforms would not also be identified. Whilst this may increase the probability of selection bias we feel this is a reflective sample sufficient to indicate the priorities and landscape of many CSDH articles.

Although this article provides evidence of the type of information provided and quantity of, it is still unclear as to how this information is received, and understood, by patients. This lack of evidence for translational efficacy is something that will be examined in due course [25]. Finally, one of two primary reviewers (CSG) had knowledge of CSDH- although this may have resulted in selective extraction and categorisation [47], dual extraction with a second reviewer not familiar with CSDH (SMc) did not identify any discrepancies.

Perspective for future research

Overall, this work confirms the need to improve education resources to support CSDH clinical care. It highlights not only a probable need amongst patients, families and carers, but also non-specialist HCP, for clear and complete education resources. The identified eight content domains for CSDH education can be a foundation for such improvements, both as a framework to develop resources and articles moving forward, but also to research establishing their specific significance to different stakeholder groups, or decision points in CSDH care.

As outlined, shared decision making is critical to a condition like CSDH, where treatment decisions such as surgery need to be contextualised to many factors [15, 25, 35]. Enabling a patient or their significant others to be an equal participant in such a conversation can only occur once they have received sufficient education. Examples of effective tools that have been developed to support this include Core Information Sets, as well as patient decision aids [43, 48]. Implicit within their design is the assumption that the healthcare professional is the ‘expert’. For CSDH, where shared decision making may be facilitated by non-specialists, this is not always the case, and this may need careful consideration during design and implementation. Addressing shared decision making for CSDH has been recognised as a major priority for improving care [49].

Conclusions

This study highlights the available resources for patients, and healthcare professionals, and their content. Education resources for CSDH contain vary considerably, with clinician-focussed resources including surgical management; and natural history, and patient focussed resources on symptoms and diagnosis. These inconsistencies, aligned with the current clinical experience of educational deficiencies, indicate a need for improved content. The development of key information domains can support this on-going process.

Supporting information

S1 Checklist. Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) checklist.

(DOCX)

S1 Data

(XLSX)

Acknowledgments

We would like to thank Dr Ali Alam, for providing feedback on the structure of the manuscript prior to submission.

Data Availability

All relevant data are within the paper and its Supporting Information files.

Funding Statement

The authors received no specific funding for this work.

References

  • 1.Kolias A.G, et al., Chronic subdural haematoma: modern management and emerging therapies. Nat Rev Neurol, 2014. 10(10): p. 570–8. doi: 10.1038/nrneurol.2014.163 [DOI] [PubMed] [Google Scholar]
  • 2.Feghali J., Yang W., and Huang J., Updates in Chronic Subdural Hematoma: Epidemiology, Etiology, Pathogenesis, Treatment, and Outcome. World Neurosurgery, 2020. 141: p. 339–345. doi: 10.1016/j.wneu.2020.06.140 [DOI] [PubMed] [Google Scholar]
  • 3.Rauhala M., et al., Chronic subdural hematoma-incidence, complications, and financial impact. Acta neurochirurgica, 2020. 162(9): p. 2033–2043. doi: 10.1007/s00701-020-04398-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Stubbs D.J., et al., Incidence of chronic subdural haematoma: a single-centre exploration of the effects of an ageing population with a review of the literature. Acta neurochirurgica, 2021. 163(9): p. 2629–2637. doi: 10.1007/s00701-021-04879-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Neifert S.N., et al., Increases in Subdural Hematoma with an Aging Population-the Future of American Cerebrovascular Disease. World Neurosurg, 2020. 141: p. e166–e174. doi: 10.1016/j.wneu.2020.05.060 [DOI] [PubMed] [Google Scholar]
  • 6.Mehta V., et al., Evidence based diagnosis and management of chronic subdural hematoma: A review of the literature. J Clin Neurosci, 2018. 50: p. 7–15. doi: 10.1016/j.jocn.2018.01.050 [DOI] [PubMed] [Google Scholar]
  • 7.Chari A., Clemente Morgado T., and Rigamonti D., Recommencement of anticoagulation in chronic subdural haematoma: a systematic review and meta-analysis. Br J Neurosurg, 2014. 28(1): p. 2–7. [DOI] [PubMed] [Google Scholar]
  • 8.Howick J., et al., Effects of empathic and positive communication in healthcare consultations: a systematic review and meta-analysis. Journal of the Royal Society of Medicine, 2018. 111(7): p. 240–252. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Stubbs D.J., et al., Identification of factors associated with morbidity and postoperative length of stay in surgically managed chronic subdural haematoma using electronic health records: a retrospective cohort study. BMJ Open, 2020. 10(6): p. e037385. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Gillespie C.S., et al., Rationalising neurosurgical head injury referrals: development and validation of the Liverpool Head Injury Tomography Score (Liverpool HITS) for mild TBI. Br J Neurosurg, 2020. 34(2): p. 127–134. doi: 10.1080/02688697.2019.1710825 [DOI] [PubMed] [Google Scholar]
  • 11.Brennan P.M., et al., The management and outcome for patients with chronic subdural hematoma: a prospective, multicenter, observational cohort study in the United Kingdom. Journal of Neurosurgery JNS, 2017. 127(4): p. 732–739. [DOI] [PubMed] [Google Scholar]
  • 12.Santarius T., et al., Use of drains versus no drains after burr-hole evacuation of chronic subdural haematoma: a randomised controlled trial. Lancet, 2009. 374(9695): p. 1067–73. [DOI] [PubMed] [Google Scholar]
  • 13.Hutchinson P.J., et al., Trial of Dexamethasone for Chronic Subdural Hematoma. N Engl J Med, 2020. 383(27): p. 2616–2627. [DOI] [PubMed] [Google Scholar]
  • 14.Freeman A.L.J., How to communicate evidence to patients. Drug and Therapeutics Bulletin, 2019. 57(8): p. 119. doi: 10.1136/dtb.2019.000008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Richards T., Coulter A., and Wicks P., Time to deliver patient centred care. BMJ: British Medical Journal, 2015. 350: p. h530. [DOI] [PubMed] [Google Scholar]
  • 16.Lopez Ramos C., et al., Assessing the Understandability and Actionability of Online Neurosurgical Patient Education Materials. World Neurosurg, 2019. 130: p. e588–e597. doi: 10.1016/j.wneu.2019.06.166 [DOI] [PubMed] [Google Scholar]
  • 17.Shlobin N.A., et al., Patient Education in Neurosurgery: Part 1 of a Systematic Review. World Neurosurg, 2021. 147: p. 202–214.e1. doi: 10.1016/j.wneu.2020.11.168 [DOI] [PubMed] [Google Scholar]
  • 18.Holl D.C., et al., Study Protocol on Defining Core Outcomes and Data Elements in Chronic Subdural Haematoma. Neurosurgery, 2021. 89(4). doi: 10.1093/neuros/nyab268 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Zimmerman M.S. and Shaw G. Jr., Health information seeking behaviour: a concept analysis. Health Info Libr J, 2020. 37(3): p. 173–191. [DOI] [PubMed] [Google Scholar]
  • 20.Jahan N., et al., How to Conduct a Systematic Review: A Narrative Literature Review. Cureus, 2016. 8(11): p. e864. doi: 10.7759/cureus.864 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Greenhalgh T., Thorne S., and Malterud K., Time to challenge the spurious hierarchy of systematic over narrative reviews? Eur J Clin Invest, 2018. 48(6): p. e12931. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Umeria R., et al., A scoping review of information provided within degenerative cervical myelopathy education resources: Towards enhancing shared decision making. PLoS One, 2022. 17(5): p. e0268220. doi: 10.1371/journal.pone.0268220 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.(SBNS), S.o.B.N.S. SBNS Website. 2021 [cited 2022 17/04/2022]; Available from: https://www.sbns.org.uk/.
  • 24.Thomas J. and Harden A., Methods for the thematic synthesis of qualitative research in systematic reviews. BMC medical research methodology, 2008. 8: p. 45–45. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Stubbs D.J., et al., Challenges and opportunities in the care of chronic subdural haematoma: perspectives from a multi-disciplinary working group on the need for change. Br J Neurosurg, 2022: p. 1–9. [DOI] [PubMed] [Google Scholar]
  • 26.Pranata R., Deka H., and July J., Subperiosteal versus subdural drainage after burr hole evacuation of chronic subdural hematoma: systematic review and meta-analysis. Acta Neurochirurgica, 2020. 162(3): p. 489–498. [DOI] [PubMed] [Google Scholar]
  • 27.Matsumoto H., et al., Which surgical procedure is effective for refractory chronic subdural hematoma? Analysis of our surgical procedures and literature review. Journal of Clinical Neuroscience, 2018. 49: p. 40–47. [DOI] [PubMed] [Google Scholar]
  • 28.Yao Z., et al., Dexamethasone for chronic subdural haematoma: a systematic review and meta-analysis. Acta Neurochir (Wien), 2017. 159(11): p. 2037–2044. [DOI] [PubMed] [Google Scholar]
  • 29.Nachiappan D.S. and Garg K., Role of prophylactic antiepileptic drugs in chronic subdural hematoma—a systematic review and meta-analysis. Neurosurgical Review, 2021. 44(4): p. 2069–2077. [DOI] [PubMed] [Google Scholar]
  • 30.Qiu S., et al., Effects of atorvastatin on chronic subdural hematoma: A systematic review. Medicine, 2017. 96(26). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Stubbs D.J., Davies B.M., and Menon D.K., Chronic subdural haematoma: the role of peri-operative medicine in a common form of reversible brain injury. Anaesthesia, 2022. 77(S1): p. 21–33. [DOI] [PubMed] [Google Scholar]
  • 32.Kwon C.S., et al., Predicting Prognosis of Patients with Chronic Subdural Hematoma: A New Scoring System. World Neurosurg, 2018. 109: p. e707–e714. [DOI] [PubMed] [Google Scholar]
  • 33.Edlmann E., et al., Pathogenesis of Chronic Subdural Hematoma: A Cohort Evidencing De Novo and Transformational Origins. J Neurotrauma, 2021. 38(18): p. 2580–2589. [DOI] [PubMed] [Google Scholar]
  • 34.Moffatt C.E., et al., Long-term health outcomes in survivors after chronic subdural haematoma. J Clin Neurosci, 2019. 66: p. 133–137. [DOI] [PubMed] [Google Scholar]
  • 35.Stubbs D.J., et al., Challenges and opportunities in the care of chronic subdural haematoma: perspectives from a multi-disciplinary working group on the need for change. British Journal of Neurosurgery, 2022: p. 1–9. [DOI] [PubMed] [Google Scholar]
  • 36.Shimizu K., et al., Importance of frailty evaluation in the prediction of the prognosis of patients with chronic subdural hematoma. Geriatr Gerontol Int, 2018. 18(8): p. 1173–1176. [DOI] [PubMed] [Google Scholar]
  • 37.Srivatsan A., et al., Middle Meningeal Artery Embolization for Chronic Subdural Hematoma: Meta-Analysis and Systematic Review. World Neurosurgery, 2019. 122: p. 613–619. [DOI] [PubMed] [Google Scholar]
  • 38.Maslow’s hammer in integrative medicine: one size will never fit all. Advances in integrative medicine, 2020. 7(3): p. 119–120. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Adhiyaman V., et al., Increasing incidence of chronic subdural haematoma in the elderly. Qjm, 2017. 110(6): p. 375–378. [DOI] [PubMed] [Google Scholar]
  • 40.Marshman L.A., Manickam A., and Carter D., Risk factors for chronic subdural haematoma formation do not account for the established male bias. Clin Neurol Neurosurg, 2015. 131: p. 1–4. [DOI] [PubMed] [Google Scholar]
  • 41.Sim Y.-W., et al., Recent changes in risk factors of chronic subdural hematoma. Journal of Korean Neurosurgical Society, 2012. 52(3): p. 234–239. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.De Bonis P., et al., Antiplatelet/anticoagulant agents and chronic subdural hematoma in the elderly. PLoS One, 2013. 8(7): p. e68732. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Kliot T., et al., The impact of a patient education bundle on neurosurgery patient satisfaction. Surg Neurol Int, 2015. 6(Suppl 22): p. S567–72. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Shlobin N.A., et al., Patient Education in Neurosurgery: Part 2 of a Systematic Review. World Neurosurg, 2021. 147: p. 190–201.e1. [DOI] [PubMed] [Google Scholar]
  • 45.Manivannan S., et al., Current Status of Websites Offering Information to Patients with Traumatic Brain Injury and Caregivers: Time for Reform? World Neurosurg, 2021. 153: p. e419–e427. doi: 10.1016/j.wneu.2021.06.140 [DOI] [PubMed] [Google Scholar]
  • 46.Allicance J.L. Anaesthesia and Perioperative Care Priority Setting Partnership. 2015. [cited 2022 24/04/2022]; Available from: https://www.niaa.org.uk/Results?newsid=1455#pt. [Google Scholar]
  • 47.Mathes T., Klaßen P., and Pieper D., Frequency of data extraction errors and methods to increase data extraction quality: a methodological review. BMC Med Res Methodol, 2017. 17(1): p. 152. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Joseph-Williams N et al. A descriptive model of shared decision making derived from routine implementation in clinical practice (‘Implement-SDM’): Qualitative study. Patient Education and Counseling, 2019. 102(10): p.1774–1785. doi: 10.1016/j.pec.2019.07.016 [DOI] [PubMed] [Google Scholar]
  • 49.Gillespie C et al. How does research activity align with research need in chronic subdural haematoma: a gap analysis of systematic reviews with end-user selected knowledge gaps. 2023. (In Press) Acta Neurochirurgica. [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Sara Rubinelli

1 Dec 2022

PONE-D-22-18696Is information provided within chronic subdural haematoma education resources adequate? A scoping reviewPLOS ONE

Dear Dr. Davies,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Both reviewers highlighted strengths of this manuscript. Yet, both of them, and especially reviewer 2, has made important recommendations for revisions that I kindly ask you to carefully address before I can make a decision about  publication. 

Please submit your revised manuscript by Jan 15 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Sara Rubinelli

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

In your revised cover letter, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide.

3. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: No

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The manuscript addresses an important gap in knowledge in CSDH information resources, and has highlighted some important findings and implications for future research. The limitations of the study have been discussed fairly well. Some points for consideration are as follows-

1. Authors have stated that ‘Selected websites were commonly accessed educational tools based on existing knowledge and experience of authors’. This is likely to have created a bias in content search. How do the authors justify this?

2. It is mentioned in the text that ‘Videos and health education websites were identified by carrying out a search using Google (CA, USA) on 9th July 2021, including the top 3 results pages’ however, it is mentioned in the figure 1 that first 10 pages were searched.

3. An important data source of self-help groups and patient care centres seems to have been excluded from the search. These centres would potentially provide information to patients, their relatives and caregivers.

4. It should be clearly mentioned how many materials were searched to identify the 56 information sources discussed in this work.

5. It is mentioned under the sub-heading ‘Core domains’ that ‘Some were designed for patients, carers and the public (39%, n=22)’. However, elsewhere it is mentioned that there were 26 patient-targeted resources.

6. ‘Risk factors’ has been identified as a separate sub-domain under domain 2. The domain 2 also has separate sub-domains for alcohol use, head injury, hypotension etc. How is the sub-domain of ‘risk factors’ different from these.

7. The statement ‘For risk factors, patient resources described more alcohol misuse (62% vs 7%, p<0.001), and antiplatelet medication use (52% vs 17%, p=0.005) than patient resources’ needs correction.

8. It is not clear what is implied by the statement ‘The overall reporting across domains was 60.7%’.

Reviewer #2: This article deals with an interesting area, that certainly needs to be known in more depth for all the aspects described in the article (first and foremost, conscious future health care choices by the patient and family and early diagnosis by non-specialist healthcare professionals).

In general, the article has many aspects that could be improved.

Next time, I recommend the inclusion of lines in the manuscript, to facilitate the review.

I included review comments as an attachment.

Please see all comments in the attached file.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: Review PLOS ONE.pdf

PLoS One. 2023 Apr 6;18(4):e0283958. doi: 10.1371/journal.pone.0283958.r002

Author response to Decision Letter 0


31 Jan 2023

Specific Comments:

- Reviewer: 1

- The manuscript addresses an important gap in knowledge in CSDH information resources, and has highlighted some important findings and implications for future research. The limitations of the study have been discussed fairly well

Thank you very much for this comment- we are grateful for the comprehensive review of the manuscript.

- 1. Authors have stated that ‘Selected websites were commonly accessed educational tools based on existing knowledge and experience of authors’. This is likely to have created a bias in content search. How do the authors justify this?

Thank you for this comment. The websites were selected as prominent patient facing, health education resources, based on popularity from internet search engines. These were identified as part of a similar review in Degenerative Cervical Myelopathy. We acknowledge however that this is not ‘comprehensive’, nor necessarily fully aligned with the CSDH population. We have expanded on this in the limitations section, and clarified this in the methods.

- 2. It is mentioned in the text that ‘Videos and health education websites were identified by carrying out a search using Google (CA, USA) on 9th July 2021, including the top 3 results pages’ however, it is mentioned in the figure 1 that first 10 pages were searched.

Our apologises for this error. We have amended this to the first 10 pages, as originally intended.

- 3. An important data source of self-help groups and patient care centres seems to have been excluded from the search. These centres would potentially provide information to patients, their relatives and caregivers.

Thank you. This is possible, but difficult to quantify particularly for a relatively infrequency diagnosis. As our aim was to identify the most commonly encountered resources available, a focus on websites accessible via searching (which is recognised as the predominant source of health information today) is pragmatic but we believe robust. We have expanded on this in the limitations section of the manuscript, Line 372-374.

- 4. It should be clearly mentioned how many materials were searched to identify the 56 information sources discussed in this work.

Our apologies- this has now been provided in the results section, Line 200.

- 5. It is mentioned under the sub-heading ‘Core domains’ that ‘Some were designed for patients, carers and the public (39%, n=22)’. However, elsewhere it is mentioned that there were 26 patient-targeted resources.

Our apologies for this. Yes, the correct number of patient-targeted resources was in fact 26, and not 22. We have amended this in the core domains sub heading (Line 213).

- 6. ‘Risk factors’ has been identified as a separate sub-domain under domain 2. The domain 2 also has separate sub-domains for alcohol use, head injury, hypotension etc. How is the sub-domain of ‘risk factors’ different from these.

Thank you . Essentially the hierarchy is as follows: the individual risk factor (e.g. head injury) was coded. These can be collapsed into the sub-domain ‘risk factors’ (e.g. resource mentioned any risk factor at least once), and again into the domain ‘Natural History and Risk Factors’ (e.g. resources covering any theme within this domain).

Whilst we acknowledge this is a little ambiguous, we feel descriptively the domain title ‘Natural History and Risk Factors’ more clearly articulates the content.

- 7. The statement ‘For risk factors, patient resources described more alcohol misuse (62% vs 7%, p<0.001), and antiplatelet medication use (52% vs 17%, p=0.005) than patient resources’ needs correction.

Our apologies for this- this has now been corrected.

- 8. It is not clear what is implied by the statement ‘The overall reporting across domains was 60.7%’.

Our apologies for the confusion- the authors meant that, when taking the overall % for each core domain covered by the resources (e.g 60% of resources cover natural history, 40% cover surgical management), the average of these was 60.7%. We have removed this statement due to its ambiguity from the revised version.

Reviewer #2

- This article deals with an interesting area, that certainly needs to be known in more depth for all the aspects described in the article (first and foremost, conscious future health care choices by the patient and family and early diagnosis by non-specialist healthcare professionals).

Thank you for this. We agree that this article emphasises an under reported area in CSDH research.

- Next time, I recommend the inclusion of lines in the manuscript, to facilitate the review.

The revised manuscript now included line numbers, and all changes have been marked with the line number they occur on for convenience.

Abstracts

- Background: it is said that CSDH is becoming prevalent, I would add a small sentence on why this is happening.

This has now been expanded upon (Lines 31-33 and 78-80).

Objectives:

- I would remove the fact that 'they are a first step'. I would include ‘analysis and exploration’ (since you are also going to use qualitative methods and you also use an explorative approach).

This statement has now been clarified to include that the aim of this paper is primarily analysis and exploration (Lines 38-40).

Introduction

Third paragraph

- (For CSDH this...), it is reported that neurosurgery is a third speciality, I would include more details on what this entails.

Thank you for this- more details have been provided (Lines 92-95).

- (These pose additional challenges in CSDH), I would add because it poses additional challenges.

Thank you for this. On reflection this sentence is confusing, and we have modified completely. (Lines 99-100).

Fourth paragraph

- (However...) must acquire sufficient knowledge.... in order to... (I would add details/reasons).

Thanks, however, we feel this is implied from the start of the sentence.

The SDM process includes relative comparisons of treatments for example. What we are trying to articulate is that without the patient understanding the nature of their condition, this cannot take place.

- (....decision-making process) I would add in '... among patients and families'. (In CSDH....unkown) I would replace unkown with a more appropriate term such as 'poorly researched', 'little information is available about it...', as something is available and exists anyway (even if not enough).

These have now been added (Lines 108-109, and Line 139)

- (In this scoping...), I would change to '...we therefore explored the information in educational resources for CSDH'.

This has now been added. Thank you (Line 110-111).

- (To consider.... relatives), as the purpose of this study is not to research themes, but these are part of the results. I would remove this sentence and put it in the methods section. (The review therefore....) I would recommend rephrasing the specific objectives in a clearer and more direct way. I would also include a specification of when the objective concerns patients, health professionals and when it concerns both.

This has been added to the methods section (Lines 124-125). Objectives have also been rephrased, and the target of each objective (patients, health professionals and both) has been added in parenthesis to each objective- (Lines 113-117).

Materials and Methods

- First paragraph: not clearly formulated. It is unclear what is meant by potential educational information and which and why it is said some publication to be defined as scientific publications (are they or are they not?). It is not clear from the paragraph what is included and what is not in the review.

Our apologies for the confusion. We have since clarified this, that scientific publications are published articles in peer reviewed journals, and educational information in any other format. (Lines 123-124).

- As specified the protocol has not been published, but can perhaps be included as supplementary information.

Our apologies a formal study protocol in document form was not prepared for this study.

Search strategy

- the use of a search methodology is indicated, please provide scientific references supporting its use.

Thanks we have added further clarification to this in the methods, and references. The approach is based on the experiences of others exploring information content in health conditions.

Figure 1

- It is not clear to the reader why the diagram is structured like this: did you start with the hospital searches that influenced subsequent searches? the diagram structured in this way could appear confusing, unless you justify why the structure is made this way (if this was done with a specific purpose). Otherwise, I would consider changing and structuring it more clearly.

Apologies for this. We agree that the diagram structure looks confusing. The diagram is simply meant to show that all of these resources were searched independently, and the combined results amalgamated into a final list of resources. We have corrected this so it is structured more clearly.

Resource type acquisition and searching

- Only narrative reviews were included: I would include the rationale for this choice, which to me seems to take away much of the other results potentially available in the literature.

We included narrative reviews as they were thought more likely to be broadly educational in nature, and therefore help establish if there was an information mis match between patients and professionals . This has been added to lines 128-130.

Figure 2

- It is not clear whether the words with a light grey background are readable (I printed out the figure in A4 but cannot read these words). Please evaluate the readability of this graphic.

Our apologies for this. We have evaluated the readability of the Figure (Figure 2 being the spider diagram)- we cannot seem to detect this difference when viewed electronically. Nonetheless, we have increased the size of all words included to attempt to ameliorate this issue, and removed any grey backgrounds.

Discussion

- In general, there is not enough evidence discussed to make sense of the results obtained, links to existing literature and perspectives for future research.

We appreciate the reviewer’s comment- substantial revisions have been made to the discussion- focussing on existing literature, and we have 2 separate paragraphs, one being ‘comparisons to previously published studies’ (Line 351) as per STROBE guidelines, and a section discussing future research ‘perspective for future research’. (Line 390).

- What is the message this scientific article carries? - I recommend rewriting this section, so that these elements are sufficiently considered. MMA (full word, if term not previously encountered).

We have added a message of the paper in the first few lines of the discussion (Lines 289-291). MMA has also now been expanded (Line 335).

Limitations and future directions

First paragraph

- (Second, the search strategy....): I would give more details as to why this method was used. Also, I wondered about the criteria for this selection, e.g. were the most recent ones included?

The reason why this method was used was to best attempt to replicate a member of the public, patient, or caregiver, when looking for resources on CSDH. This has been added to the paragraph (Lines 375).

Second paragraph

- (Third, although....) I would not include this as a limitation as this is not part of the objectives of this study and therefore not a limitation (but part of a future study perhaps). If anything, it is a paragraph that could be included in the section 'perspective for future research'.

Thank you for this suggestion- we have added an additional subheading ‘Perspective for future research’ in accordance with the reviewers suggestion (Line 390).

- (Finally,....) I would add reasons why the fact that one of the researchers knows the topic influences the results (on what assumption is this statement based and perhaps some references that support it). As said, if this limitation is confirmed and supported, references are needed. I would also include a sentence about how the authors tried to overcome and reduce the risk of this influence.

Thank you for this- we have expanded on this. (Lines 386-388).

- (This emcompass....analysis): I think this sentence is not needed here (this could be relevant to the Methods section).

This has now been removed. Thank you.

- (This review...process) I would state here that …in general future research perspectives in this area are....

This has now been added (Lines 401-402).

- I would not include ‘a link’ to a specific future study, which has not yet been published and about which we do not know when it will be available in scientific literature.

We agree with this viewpoint: this has now been modified to say that this could represent a future area of research, without linking the present article to a future study that has not yet happened yet.

- I would add a few sentences on the value of the results in the clinical perspective and with respect to the use of services (I recommend to reflect on this and make a connection between the results and the aforementioned areas).

This has been reflected on (Line 399).

Conclusion

- In my opinion, it should be reformulated.

Thank you for this. We have reformatted the conclusion accordingly.

- I would add what is the added value of this study and the message it carries, as well as the value of these results in a general way.

This has been added to line 398.

- I would consider the inclusion of 'Supplementary table S1. Differences in domain components between patient orientated and healthcare professional orientated resources.' in the article itself, as this is part of the focus of the article. If preferred as supplementary, argue why and make a clear link within the manuscript on this to invite the reader to go and see the attached table.

Thanks- we have now included the Supplementary Table 1 as a table in the manuscript itself (Table 2)

- All the recommended changes can make this article more readable and clear for the reader.

We hope the incorporation of these changes will make the manuscript more clear after the reviewer’s suggestions.

Attachment

Submitted filename: Response to editor and reviewer comments BMD 21.01.docx

Decision Letter 1

Sara Rubinelli

7 Mar 2023

PONE-D-22-18696R1Is information provided within chronic subdural haematoma education resources adequate? A scoping reviewPLOS ONE

Dear Dr. Davies,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

The reviewers much appreciated the revisions. But one of them still has some suggestions that I kindly ask you to address before I can make the final decision on publication. 

Please submit your revised manuscript by Apr 21 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Sara Rubinelli

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: N/A

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: No

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)

Reviewer #2: An external file with the comments has been attached.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: Reviewers Comments.pdf

Decision Letter 2

Sara Rubinelli

21 Mar 2023

Is information provided within chronic subdural haematoma education resources adequate? A scoping review

PONE-D-22-18696R2

Dear Dr. Davies,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Sara Rubinelli

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: (No Response)

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: (No Response)

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: (No Response)

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: (No Response)

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

**********

Acceptance letter

Sara Rubinelli

28 Mar 2023

PONE-D-22-18696R2

Is information provided within chronic subdural haematoma education resources adequate? A scoping review

Dear Dr. Davies:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Sara Rubinelli

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Checklist. Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) checklist.

    (DOCX)

    S1 Data

    (XLSX)

    Attachment

    Submitted filename: Review PLOS ONE.pdf

    Attachment

    Submitted filename: Response to editor and reviewer comments BMD 21.01.docx

    Attachment

    Submitted filename: Reviewers Comments.pdf

    Attachment

    Submitted filename: Response to editor and reviewer comments 12.03.docx

    Data Availability Statement

    All relevant data are within the paper and its Supporting Information files.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES